We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Urine Particle Analyzer Compared with Standard Methods

By LabMedica International staff writers
Posted on 20 Nov 2017
Urinary tract infections (UTIs) are characterized by the presence of microbial pathogens within the urinary tract, and they represent one of the most common infections identified in both hospitalized and clinic patients. More...
Most UTIs are easily treated without difficulty.

In certain patient populations, such as children, pregnant women, and the elderly, significant complications may arise. The symptoms observed with UTIs are diverse and can range from mild irritation with voiding to bacteremia or even sepsis. When sepsis is present, it can lead to death if it is not diagnosed and treated early.

Medical scientists working at Prescient Medicine (Hummelstown, PA, USA) and their colleagues compared data from urine samples collected in sterile containers for bacterial culture and microscopic analysis during a 3-month period in a laboratory at a 572-bed, acute-care hospital. Upon receipt, one sample was used to inoculate a 5% sheep blood agar and a MacConkey agar plate with a 0.001-mL calibrated loop.

The second sample was analyzed for bacteria and leukocytes with the Sysmex UF-1000i urine analyzer (Sysmex Corporation, Kobe, Japan) which is a fully automated, fluorescent flow cytometer that categorizes red blood cells, white blood cells, epithelial cells, small round cells, sperm cells, crystals, and pathologic and hyaline casts, yeast, and bacteria. The second sample was also analyzed by urinalysis-associated microscopy for the presence of epithelial cells, leukocytes, yeast, and bacteria.

Urine cultures showed no growth in 2,034 samples (50%) and growth of less than 104 colony-forming units (CFUs)/mL in 1,812 samples (45%). Of the 4.033 results, 754 samples (19%) showed bacterial growth of 105 CFUs/mL or more, and 190 samples (5%) were considered contaminated specimens because they contained multiple species. However, if the growth of bacteria exceeded the definition of a negative result, they were considered to be positive, even though the likelihood of a UTI was low in those patients. Of the culture-positive samples, the most commonly identified microorganisms were Escherichia coli and Klebsiella spp, which is consistent with known epidemiologic data.

Of the 4,033 unique urine samples obtained from adult patients, 2,736 (67.8%) specimens had positive white blood cell counts and bacteria and 1,215 (30.1%) specimens had negative white blood cell counts and bacteria as reported by the UF-1000i. The negative predictive value for any positive culture in the adult population included in the study was 95.5%, and the negative predictive value for positive cultures containing growth of 100,000 or more CFUs was 99.3% using the Sysmex UF-1000i. There were 373 unique urine specimens collected in pediatric patients and using the UF-1000i method, 269 specimens (72%) had positive white blood cell counts and bacteria, and 104 (27.9%) tested negative for an elevation in white blood cell counts and bacteria.

The authors concluded that the Sysmex UF-1000i showed 98% sensitivity and 93.7% specificity with a 95.5% negative predictive value. Thus, a negative screen with the UF-1000i using defined thresholds for white blood cell counts and bacteria was likely to be a true negative, decreasing the need for presumptive antibiotics. The study was published in the November 2017 issue of the journal Archives of Pathology & Laboratory Medicine.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.